We are live on ! Find out more
RBFC

Roman Butler Fullerton & Co Portfolio holdings

AUM $419M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
+12.95%
1 Year Est. Return
+31.15%
3 Year Est. Return
+120.62%
5 Year Est. Return
+172.72%
10 Year Est. Return
AUM
$169M
AUM Growth
+$16.5M
Cap. Flow
+$390K
Cap. Flow %
0.23%
Top 10 Hldgs %
27.92%
Holding
180
New
27
Increased
90
Reduced
38
Closed
10

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$1.09M
2
T icon
AT&T
T
+$1.09M
3
CI icon
Cigna
CI
+$999K
4
ILCG icon
iShares Morningstar Growth ETF
ILCG
+$887K
5
BABA icon
Alibaba
BABA
+$830K

Sector Composition

Rank Sector Weight
1 Technology 24.03%
2 Communication Services 8.61%
3 Financials 8.25%
4 Consumer Staples 7.98%
5 Healthcare 7.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MMM icon
176
3M
MMM
$94.4B
-2,650
Closed -$355K
REGN icon
177
Regeneron Pharmaceuticals
REGN
$82.1B
-1,401
Closed -$784K
UPS icon
178
United Parcel Service
UPS
$88.8B
-3,092
Closed -$515K
VEEV icon
179
Veeva Systems
VEEV
$38.4B
-1,487
Closed -$418K
VRTX icon
180
Vertex Pharmaceuticals
VRTX
$134B
-4,008
Closed -$1.09M

Similar funds

Roman Butler Fullerton & Co's Q4 2020 Portfolio in Review

As of Q4 2020, Roman Butler Fullerton & Co held 180 positions worth $169M, up 11% from $153M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Roman Butler Fullerton & Co's Q4 2020 filing shows 27 new, 90 increased, 38 reduced and 10 closed positions. Its largest new stake was Entegris: 8,447 shares worth $812K. The largest sale was Vertex Pharmaceuticals, an estimated $1.09M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Communication Services and Financials.

  • Roman Butler Fullerton & Co's largest Q4 2020 buy was Entegris: 8,447 shares worth $812K.
  • Roman Butler Fullerton & Co added most to Apple in Q4 2020, an estimated $525K increase.
  • Roman Butler Fullerton & Co's biggest Q4 2020 reduction was AT&T, cutting an estimated $1.09M.
  • Roman Butler Fullerton & Co fully exited Vertex Pharmaceuticals in Q4 2020, selling an estimated $1.09M.
  • Roman Butler Fullerton & Co's ten largest holdings make up 28% of its $169M portfolio in Q4 2020.
  • Roman Butler Fullerton & Co opened 27 new positions and closed 10 in Q4 2020.
  • Roman Butler Fullerton & Co's portfolio value rose 11% quarter-over-quarter to $169M.

Based on Roman Butler Fullerton & Co's 13F filing for Q4 2020, filed 1 Feb 2021.